Cargando…

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

The RAS/MAPK-signalling pathway is frequently deregulated in non-small cell lung cancer (NSCLC), often through KRAS activating mutations(1-3). A single endogenous mutant Kras allele is sufficient to promote lung tumour formation in mice but malignant progression requires additional genetic alteratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerr, Emma, Gaude, Edoardo, Turrell, Frances, Frezza, Christian, Martins, Carla P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780242/ https://www.ncbi.nlm.nih.gov/pubmed/26909577 http://dx.doi.org/10.1038/nature16967

Ejemplares similares

Metabolic Reprograming of Mononuclear Phagocytes in Progressive Multiple Sclerosis
por: Tannahill, Gillian Margaret, et al.
Publicado: (2015)

Defects in mitochondrial metabolism and cancer
por: Gaude, Edoardo, et al.
Publicado: (2014)

Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
por: Gaude, Edoardo, et al.
Publicado: (2016)

Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer
por: Liu, Huashan, et al.
Publicado: (2021)

Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells
por: Suzuki, Tatsunori, et al.
Publicado: (2021)

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
por: Xiang, Luochengling, et al.
Publicado: (2020)

Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers
por: Benstead-Hume, Graeme, et al.
Publicado: (2019)

Copy number variation and susceptibility to complex traits
por: Canales, Cesar P, et al.
Publicado: (2011)

PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas
por: Nakae, Shunsuke, et al.
Publicado: (2015)

Copy number variation in the susceptibility to systemic lupus erythematosus
por: Barbosa, Fernanda Bueno, et al.
Publicado: (2018)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
por: Gilbert-Dussardier, Brigitte, et al.
Publicado: (2016)

Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
por: Adachi, Yuta, et al.
Publicado: (2021)

CCL3L1 copy number and susceptibility to malaria
por: Carpenter, Danielle, et al.
Publicado: (2012)

Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients
por: Fung, Andrea S., et al.
Publicado: (2021)

Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
por: Liu, Weiran, et al.
Publicado: (2016)

Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
por: Knickelbein, Kyle, et al.
Publicado: (2014)

Therapeutic Approach of KRAS Mutant Tumours by the Combination of Pharmacologic Ascorbate and Chloroquine
por: Kapuy, Orsolya, et al.
Publicado: (2021)

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer
por: Mamlouk, Soulafa, et al.
Publicado: (2017)

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2019)

The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility
por: Signore, Fabrizio, et al.
Publicado: (2019)

LILRA6 copy number variation correlates with susceptibility to atopic dermatitis
por: López-Álvarez, M. R., et al.
Publicado: (2016)

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
por: Pang, Xiufeng, et al.
Publicado: (2016)

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2020)

Identification of Copy Number Variants Defining Genomic Differences among Major Human Groups
por: Armengol, Lluís, et al.
Publicado: (2009)

Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
por: Silveira, Sara Martoreli, et al.
Publicado: (2013)

Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations
por: Kim, Young-Ho, et al.
Publicado: (2016)

Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
por: Hasan, A. M. Mahedi, et al.
Publicado: (2023)

KRAS mutant lung cancer: progress thus far on an elusive therapeutic target
por: Bhattacharya, Saveri, et al.
Publicado: (2015)

An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
por: Wang, Haiyun, et al.
Publicado: (2019)

Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2019)

Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2022)

In vivo reprogramming drives Kras-induced cancer development
por: Shibata, Hirofumi, et al.
Publicado: (2018)

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
por: Hamidi, H, et al.
Publicado: (2014)

Defeat mutant KRAS with synthetic lethality
por: Pang, Xiufeng, et al.
Publicado: (2016)

The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
por: Diehl, J. Nathaniel, et al.
Publicado: (2021)

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
por: Hammond, Dean E., et al.
Publicado: (2015)

E2F1 germline copy number variations and melanoma susceptibility
por: Rocca, Maria Santa, et al.
Publicado: (2019)

Association of VPREB1 Gene Copy Number Variation and Rheumatoid Arthritis Susceptibility
por: Aslam, Muhammad Muaaz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m33edmlsr61joceppct8ron2pj